Fundz

Selux Diagnostics Announces Additional $50 Million In Series C Funding

PRIVATEFeb 28, 2022

Amount Raised

$50 Million

Round Type

Series C

BostonBiotechnologyHealth CareScience And EngineeringSports

Description

Selux Diagnostics, Inc., which is leading a new era in personalized diagnostics to combat superbug infections and fight antibiotic resistance, today announced it has raised $50 million in Series C financing to support the U.S. commercial launch of its Next-Generation Phenotyping (NGP) rapid Antimicrobial Susceptibility Testing (AST) platform.

Quick answer

SeLux Diagnostics, Inc. raised $50 Million in a Series C round, dated February 28, 2022. SeLux Diagnostics, Inc. is based in Boston, Massachusetts, United States.

How much did SeLux Diagnostics, Inc. raise?
SeLux Diagnostics, Inc. raised $50 Million in a Series C round on February 28, 2022.
What does SeLux Diagnostics, Inc. do?
The Selux platform will become the system of choice for healthcare providers dedicated to providing best-in-class septic and other infectious diseases patient care." In September 2021, the company received Breakthrough..
Where is SeLux Diagnostics, Inc. based and how big is it?
SeLux Diagnostics, Inc. is based in Boston, Massachusetts, United States.
Who are the decision-makers at SeLux Diagnostics, Inc?
Fundz holds 1 contact at SeLux Diagnostics, Inc., including the Executive Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Science And Engineering and Sports around the same time

Companies in the same sectors as SeLux Diagnostics, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Surf Bio raised $16M (Seed) on April 12, 2022.
  • Trait Biosciences Inc. raised $210K (Series A) on April 6, 2022.
  • Ensem Therapeutics raised $67M (Series A) on April 6, 2022.
  • Ray Therapeutics raised $6M on April 5, 2022.
  • Zephyr AI, Inc. raised $18M on April 4, 2022.
  • 2seventy bio raised $170M on March 31, 2022.

Who to call at SeLux Diagnostics, Inc., and when

A new round usually means SeLux Diagnostics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day SeLux Diagnostics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at SeLux Diagnostics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at SeLux Diagnostics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

SeLux Diagnostics, Inc.

Location

56 ROLAND STREET

Boston, Massachusetts, United States

About

The Selux platform will become the system of choice for healthcare providers dedicated to providing best-in-class septic and other infectious diseases patient care." In September 2021, the company received Breakthrough Device Designation from the FDA for positive blood culture and sterile body fluid sample indications for NGP. In October 2021, the company received a $2.8 million award from the U.S. National Institutes of Health (NIH) to help commercialization efforts.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment SeLux Diagnostics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsJack P., Executive OfficerSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for SeLux Diagnostics, Inc.'s next move

See what Strategic adds

SeLux Diagnostics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.